Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Arena

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Management and Research|October 23, 2014
Clinical implications of recent studies using mTOR inhibitors to treat advanced hormone receptor-positive breast cancerFrancis Arena
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Multimodality data fusion aids early detection of breast cancer using conventional technology and advanced digital infrared imagingFrancis Arena, Thomas DiCicco, Azad Anand
Current Treatment Options in Gastroenterology|October 7, 2016
Interactions Between Inflammatory Bowel Disease Drugs and ChemotherapyGalen Leung, Marianna Papademetriou, Shannon Chang, et al.
Chemotherapy|September 10, 2002
Comparative study of antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients of Caracas and Asunción in a 4-year-periodAlfonso J Rodríguez, D R Antonio Samaniego, Ana Soskin, et al.
Oncology (Williston Park, N.Y.)|January 11, 2012
Perspective on...the new PSA screening recommendationsThomas Marsland, Francis Arena, Alan Yeilding, et al.
The Lancet. Oncology|April 19, 2014
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trialFabrice André, Ruth O'Regan, Mustafa Ozguroglu, et al.
European Journal of Cancer (Oxford, England : 1990)|June 6, 2013
Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: subgroup analysis from the BOLERO-2 studyMario Campone, Thomas Bachelot, Michael Gnant, et al.
Cancer|February 11, 2004
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignanciesPaul J Hesketh, Francis Arena, Dhimant Patel, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Management and Research|October 23, 2014
Clinical implications of recent studies using mTOR inhibitors to treat advanced hormone receptor-positive breast cancerFrancis Arena
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Multimodality data fusion aids early detection of breast cancer using conventional technology and advanced digital infrared imagingFrancis Arena, Thomas DiCicco, Azad Anand
Current Treatment Options in Gastroenterology|October 7, 2016
Interactions Between Inflammatory Bowel Disease Drugs and ChemotherapyGalen Leung, Marianna Papademetriou, Shannon Chang, et al.
Chemotherapy|September 10, 2002
Comparative study of antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients of Caracas and Asunción in a 4-year-periodAlfonso J Rodríguez, D R Antonio Samaniego, Ana Soskin, et al.
Oncology (Williston Park, N.Y.)|January 11, 2012
Perspective on...the new PSA screening recommendationsThomas Marsland, Francis Arena, Alan Yeilding, et al.
The Lancet. Oncology|April 19, 2014
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trialFabrice André, Ruth O'Regan, Mustafa Ozguroglu, et al.
European Journal of Cancer (Oxford, England : 1990)|June 6, 2013
Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: subgroup analysis from the BOLERO-2 studyMario Campone, Thomas Bachelot, Michael Gnant, et al.
Cancer|February 11, 2004
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignanciesPaul J Hesketh, Francis Arena, Dhimant Patel, et al.
Pageof 1